Study On The Clinical Efficacy Of Chaihu Guizhi Decoction In The Treatment Of Cervical Spondylosis Of Cervical Type (wind-cold-dampness Type)

Objective:To compare the clinical efficacy and adverse reactions of Chaihu Guizhi Decoction in the treatment of patients with cervical spondylosis between the observation group and the control group,and to evaluate the effectiveness of Chaihu Guizhi Decoction in the treatment of cervical spondylosis.It is a clinical treatment for cervical spondylopathy Provide new ideas.Materials and methods:In this study,a prospective cohort study was used to collect and sort out recent clinical case data of patients with cervical spondylosis,and select 84 patients who attended the Department of Orthopedics,Affiliated Hospital of Liaoning University of Traditional Chinese Medicine from September 2018 to October 2020.The selected patients were all diagnosed by Western medicine as cervical spondylopathy and no other types of cervical spondylosis.The Chinese medicine diagnosed as Xiangbi,and the syndrome type was wind-cold-dampness-type.The 84 study subjects were divided into two groups according to the patient's choice of treatment plan,each with 42 people.The observation group was treated with conventional western medicine orally combined with traditional Chinese medicine decoction.The western medicine treatment method was oral meloxicam tablets 7.5 mg once a day.On this basis,Chaihu Guizhi Decoction was added,and the prescriptions consisted of 15g of Bupleurum,10g of Guizhi,10g of Pinellia 10g,10g of Scutellaria,10g of Ginseng,10g of White Peony,10g of Ginger,3 Jujubes,and 8g of Licorice.Decoction in water and warm,once in the morning and evening,once a day,for 2 weeks of continuous treatment;the control group was treated with conventional western medicine,oral meloxicam tablets 7.5 mg once a day for 2 weeks.After two weeks of treatment,observe the patient's clinical efficacy,evaluate the patient's VAS score,CROM score,NDI score,evaluation of the efficacy of TCM syndromes and imaging evaluation.Result:1.Case selection status:A total of 84 patients were selected,and 4 people were dropped out during the study,including 2 in the control group and 2 in the observation group.The final number of participants in the comparison of the results of the study was 80.The two weeks of treatment were completed according to the study plan and completed Follow-up for 2 weeks.2.The comparison of VAS,CROM and NDI scores between the two groups of patients before treatment(P>0.05)was not statistically significant.After two weeks of treatment,the comparison within the two groups was statistically significant(P<0.05).There was a significant difference(P<0.05).The observation group was significantly better than the control group in terms of the clinical control rate of TCM syndrome curative effect evaluation.3.After two weeks of treatment,the symptoms of the two groups of patients were relieved to varying degrees,but from the comparison of the VAS,CROM,NDI scores and the evaluation of the efficacy of TCM syndromes,it can be known that the efficacy of the observation group was significantly better than that of the control group.4.In the two-week clinical study,the patients had no obvious adverse reactions before and after treatment,indicating that the safety of this study is good.In conclusion:The efficacy of oral meloxicam tablets combined with Chaihu Guizhi Decoction in the treatment of cervical cervical spondylosis is significantly better than that of oral meloxicam tablets alone,and there are no obvious adverse reactions,high safety,and further development and application in clinical value.